Depression is common among pregnant women and, untreated, is associated with morbidity in both mother and child.
But what about the risks of treatment?
A large database study from the US, with information on the timing, dose, and type of antidepressant treatment in pregnancy, identifies a dose dependent increase in risk for newborn respiratory distress and a small increase in risk of preterm birth in those taking higher doses.



One thought on “Linking Prenatal Antidepressant Use & Risk of Adverse Neonatal Outcomes”